ZURICH, Sept 28 (Reuters) - Switzerland’s Novartis AG (NOVN.VX: Quote, Profile, Research) said on Friday it would invest $65 million in research at Massachusetts Institute of Technology over the next 10 years to develop new ways of manufacturing drugs.
